
|Videos|December 23, 2020
Dr. Adam J. Gadzinski describes the emergence of precision medicine in prostate cancer
Author(s)Urology Times staff
Urologist Adam J. Gadzinski, MD, MS, shares his excitement about the dawn of the precision medicine era in prostate cancer.
Advertisement
In this video, Adam J. Gadzinski, MD, MS, highlights how precision medicine in prostate cancer was a key topic at the 2020 Society of Urologic Oncology Annual Meeting and marks the next great leap forward in the field. Gadzinski is an acting instructor of urologic oncology at the Urology Clinic at the University of Washington Medical Center.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
3
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
4
Urocross shows sustained benefit through 24 months post-removal
5












